T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Zoom
ZM
|
+$3.3B |
| 2 |
Eli Lilly
LLY
|
+$2.75B |
| 3 |
AstraZeneca
AZN
|
+$1.98B |
| 4 |
Coupang
CPNG
|
+$1.54B |
| 5 |
Fortinet
FTNT
|
+$1.48B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
NXP Semiconductors
NXPI
|
+$2.34B |
| 2 |
Morgan Stanley
MS
|
+$2.26B |
| 3 |
Airbnb
ABNB
|
+$2.04B |
| 4 |
Qualcomm
QCOM
|
+$1.95B |
| 5 |
NVIDIA
NVDA
|
+$1.81B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 23.35% |
| 2 | Healthcare | 16.19% |
| 3 | Consumer Discretionary | 15.55% |
| 4 | Financials | 12.84% |
| 5 | Communication Services | 12.27% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1026
Zentalis Pharmaceuticals
ZNTL
$297M
| $47M | ﹤0.01% |
1,084,246
-9,780
| -0.9% | -$421K |
|
1027
Uber
UBER
$155B
| $46.8M | ﹤0.01% |
858,241
-680,717
| -44% | -$38M |
|
|
CERE
1028
DELISTED
Cerevel Therapeutics Holdings, Inc. Common Stock
CERE
| $46.7M | ﹤0.01% |
3,399,888
+7,755
| +0.2% | +$113K |
|
1029
Brown-Forman Class B
BF.B
$12.9B
| $46.6M | ﹤0.01% |
675,812
+16,029
| +2% | +$1.17M |
|
|
TPH
1030
DELISTED
Tri Pointe Homes
TPH
| $46.6M | ﹤0.01% |
2,287,479
-1,078,773
| -32% | -$21.2M |
|
1031
Travel + Leisure Co
TNL
$4.58B
| $46.5M | ﹤0.01% |
760,310
+677,273
| +816% | +$36.8M |
|
1032
Chewy
CHWY
$9.2B
| $46.2M | ﹤0.01% |
545,678
-2,788
| -0.5% | -$271K |
|
|
SAFE
1033
DELISTED
Safehold Inc.
SAFE
| $46.1M | ﹤0.01% |
657,887
+55,809
| +9% | +$4.22M |
|
|
INVX
1034
Innovex International
INVX
$2.15B
| $45.8M | ﹤0.01% |
1,378,088
-15,957
| -1% | -$548K |
|
|
HHR
1035
DELISTED
HeadHunter Group PLC American Depositary Shares
HHR
| $45.5M | ﹤0.01% |
1,342,107
-38,200
| -3% | -$1.23M |
|
1036
ResMed
RMD
$32.9B
| $45.4M | ﹤0.01% |
233,934
-14,833
| -6% | -$2.97M |
|
1037
Insperity
NSP
$2.05B
| $45.3M | ﹤0.01% |
540,510
-30,420
| -5% | -$2.59M |
|
|
1038
Airbnb
ABNB
$111B
| $45.2M | ﹤0.01% |
240,764
-10,991,636
| -98% | -$2.04B |
|
|
PDCE
1039
DELISTED
PDC Energy, Inc.
PDCE
| $45.1M | ﹤0.01% |
1,311,129
+1,255,050
| +2,238% | +$37.7M |
|
1040
Huntsman Corp
HUN
$1.81B
| $45.1M | ﹤0.01% |
1,564,284
-401,396
| -20% | -$11.2M |
|
1041
CAE Inc. Common Shares
CAE
$8.47B
| $45M | ﹤0.01% |
1,580,539
-63,716
| -4% | -$1.69M |
|
1042
Apollo Global Management
APO
$84.8B
| $45M | ﹤0.01% |
957,307
+868,056
| +973% | +$42.2M |
|
1043
Curtiss-Wright
CW
$25.4B
| $45M | ﹤0.01% |
379,207
-125,092
| -25% | -$14.5M |
|
|
HCCI
1044
DELISTED
Heritage-Crystal Clean, Inc.
HCCI
| $44.9M | ﹤0.01% |
1,655,006
-55,368
| -3% | -$1.39M |
|
1045
Chemed
CHE
$7.02B
| $44.8M | ﹤0.01% |
97,376
-14,753
| -13% | -$7.23M |
|
|
ABMD
1046
DELISTED
Abiomed Inc
ABMD
| $44.7M | ﹤0.01% |
140,190
-188
| -0.1% | -$60.2K |
|
1047
Blackbaud
BLKB
$2.1B
| $44.3M | ﹤0.01% |
623,411
-89,759
| -13% | -$6.19M |
|
1048
LyondellBasell Industries
LYB
$20.2B
| $43.7M | ﹤0.01% |
420,171
-29,024
| -6% | -$2.88M |
|
|
HAYN
1049
DELISTED
Haynes International, Inc.
HAYN
| $43.6M | ﹤0.01% |
1,471,018
-46,015
| -3% | -$1.24M |
|
1050
Ameriprise Financial
AMP
$50.4B
| $43.5M | ﹤0.01% |
187,205
-19,254
| -9% | -$4.16M |
|
Similar funds
T. Rowe Price Associates's Q1 2021 Portfolio in Review
As of Q1 2021, T. Rowe Price Associates held 2,908 positions worth $999B, up 2.5% from $974B the previous quarter. Its ten largest holdings account for 24% of the portfolio.
T. Rowe Price Associates's Q1 2021 filing shows 248 new, 1,171 increased, 1,334 reduced and 66 closed positions. Its largest new stake was Coupang: 33,380,859 shares worth $1.63B. The largest sale was NXP Semiconductors, an estimated $2.34B.
By sector, the portfolio is most concentrated in Technology at 23% of assets, down from 25% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- T. Rowe Price Associates's largest Q1 2021 buy was Coupang: 33,380,859 shares worth $1.63B.
- T. Rowe Price Associates added most to Zoom in Q1 2021, an estimated $3.3B increase.
- T. Rowe Price Associates's biggest Q1 2021 reduction was NXP Semiconductors, cutting an estimated $2.34B.
- T. Rowe Price Associates fully exited CONCHO RESOURCES INC. in Q1 2021, selling an estimated $205M.
- T. Rowe Price Associates's ten largest holdings make up 24% of its $999B portfolio in Q1 2021.
- T. Rowe Price Associates opened 248 new positions and closed 66 in Q1 2021.
- T. Rowe Price Associates's portfolio value rose 2.5% quarter-over-quarter to $999B.
Based on T. Rowe Price Associates's 13F filing for Q1 2021, filed 17 May 2021.